Free Trial

Inhibikase Therapeutics (IKT) Insider Trading & Ownership

Inhibikase Therapeutics logo
$1.86 -0.04 (-2.11%)
Closing price 04:00 PM Eastern
Extended Trading
$1.86 0.00 (0.00%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Inhibikase Therapeutics (NASDAQ:IKT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
7.30%
Number Of
Insiders Buying
(Last 3 Years)
1
Amount Of
Insider Buying
(Last 3 Years)
$198.65K
Number Of
Insiders Selling
(Last 3 Years)
0
Get IKT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Inhibikase Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IKT Insider Buying and Selling by Quarter

Inhibikase Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/21/2024
Arvind Kush
Director
Buy145,000$1.37$198,650.00  
(Data available from 1/1/2013 forward)

IKT Insider Trading Activity - Frequently Asked Questions

The list of insiders at Inhibikase Therapeutics includes Arvind Kush. Learn more on insiders at IKT.

7.30% of Inhibikase Therapeutics stock is owned by insiders. Learn more on IKT's insider holdings.

The following insider purchased IKT shares in the last 24 months: Arvind Kush ($198,650.00).

Insiders have purchased a total of 145,000 IKT shares in the last 24 months for a total of $198,650.00 bought.

Inhibikase Therapeutics Active Insiders



This page (NASDAQ:IKT) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners